Related Experiment Video
Updated: Apr 24, 2026

03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
1.2K
Conditional survival in patients with thyroid cancer.
Mousumi Banerjee1, Daniel G Muenz, Francis P Worden
11 Department of Biostatistics, University of Michigan , Ann Arbor, Michigan.
Thyroid : Official Journal of the American Thyroid Association
|September 12, 2014
Summary
Survival for well-differentiated thyroid cancer patients improves over time, especially for distant stages. Factors like cancer stage, age, and gender significantly impact long-term survival outcomes.
Area of Science:
- Oncology
- Epidemiology
- Biostatistics
Background:
- Thyroid cancer is a growing health concern.
- Survival rates for well-differentiated thyroid cancer vary by severity.
- The impact of time since diagnosis on patient life expectancy is not well understood.
Purpose of the Study:
- To investigate how life expectancy changes over time for well-differentiated thyroid cancer patients.
- To analyze conditional survival estimates based on disease severity and patient demographics.
Main Methods:
- Utilized data from 43,392 patients diagnosed with well-differentiated thyroid cancer (1998-2005) from the SEER registry.
- Followed patients for up to 12 years to assess disease-specific survival.
- Employed Cox proportional hazards regression to calculate conditional survival estimates by SEER stage and age.
Main Results:
- Localized thyroid cancer shows excellent, stable conditional survival.
- Regional thyroid cancer has relatively stable conditional survival.
- Distant thyroid cancer demonstrates gradual survival improvement over time.
- Age and male gender significantly influence disease-specific survival, particularly in regional and distant stages.
Conclusions:
- Cancer stage, age at diagnosis, gender, and time survived are key factors in conditional survival for thyroid cancer.
- Understanding conditional survival is crucial for personalized treatment planning and surveillance strategies.
Related Concept Videos
Cancer Survival Analysis
857
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
857
Hyperthyroidism I: Introduction
11
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
11
Hyperthyroidism II: Pathophysiology
10
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
10
Graves' Disease I: Introduction
13
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
13
Graves Disease II: Pathophysiology
14
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
14
The Thyroid Gland
6.8K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
6.8K

